Role of Targeted Therapies in Advanced Cholangiocarcinoma

home / investigator-perspectives / role-of-targeted-therapies-in-advanced-cholangiocarcinoma

Saeed Sadeghi, MD, comments on the utilization of FGFR2 inhibitors as treatment for advanced cholangiocarcinoma.

Advanced Cholangiocarcinoma: Current Treatment Landscape

EP. 1: Advanced Cholangiocarcinoma: Current Treatment Landscape

Targeted Oncology
July 10th 2020

Watch

Driver Mutations in Advanced Cholangiocarcinoma

EP. 2: Driver Mutations in Advanced Cholangiocarcinoma

Targeted Oncology
July 10th 2020

Watch

FGFR2 Inhibitors in Advanced Cholangiocarcinoma

EP. 3: FGFR2 Inhibitors in Advanced Cholangiocarcinoma

Targeted Oncology
July 10th 2020

Watch

Advanced Cholangiocarcinoma: FGFR2 Inhibitors vs Chemo

EP. 4: Advanced Cholangiocarcinoma: FGFR2 Inhibitors vs Chemo

Targeted Oncology
July 10th 2020

Watch

Optimizing Therapy for Advanced Cholangiocarcinoma

EP. 5: Optimizing Therapy for Advanced Cholangiocarcinoma

Targeted Oncology
July 10th 2020

Watch